US OptionsDetailed Quotes
RXRX241206C4000
- 0.00
- 0.000.00%
15min DelayTrading Dec 4 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest4.00Strike Price0.00Turnover1516.47%IV-44.57%PremiumDec 6, 2024Expiry Date3.22Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8595Delta0.0276Gamma2.22Leverage Ratio-0.5116Theta0.0001Rho1.91Eff Leverage0.0012Vega
Recursion Pharmaceuticals Stock Discussion
Sign in to post a comment
$Recursion Pharmaceuticals (RXRX.US)$
“The evolution of precision and personalized treatment options for oncology patients provide promising alternatives,” says William McKean, MD, Clinical Investigator at START Mountain Region in Salt Lake City, Utah. “We are so pleased to be working with Recursion as a participating site in the DAHLIA trial, and look forward to advancing the science of cancer treatment.”
“The evolution of precision and personalized treatment options for oncology patients provide promising alternatives,” says William McKean, MD, Clinical Investigator at START Mountain Region in Salt Lake City, Utah. “We are so pleased to be working with Recursion as a participating site in the DAHLIA trial, and look forward to advancing the science of cancer treatment.”
3
1
This year, the hottest AI trends may be shifting from "hard tech" to practical application scenarios. AI advertising marketing leader $Applovin (APP.US)$'s stock soared by 745% year-to-date, $Palantir (PLTR.US)$ has seen a substantial increase of 290%, while AI chip giant $NVIDIA (NVDA.US)$ has risen by 179%.
Goldman Sachs also pointed out in a previous report that by 2025, investors are expected to shift from AI infrastructure to a broader "t...
Goldman Sachs also pointed out in a previous report that by 2025, investors are expected to shift from AI infrastructure to a broader "t...
+1
105
7
182
$Recursion Pharmaceuticals (RXRX.US)$ NFA, JUST RISKY OPINIONS! Room to grow?
1
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$Recursion Pharmaceuticals (RXRX.US)$2 Innovative Stocks That Could Deliver Outsize Returns | The Motley Fool
No comment yet
一个来自马来的韭菜 : Buy on the pullback for an uptrend.